Published in J Nutr on February 01, 1997
Alcohol and HIV disease progression: weighing the evidence. Curr HIV/AIDS Rep (2010) 1.64
Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients (2011) 1.11
Relationship between food insecurity and mortality among HIV-positive injection drug users receiving antiretroviral therapy in British Columbia, Canada. PLoS One (2013) 1.01
Malaria, intestinal helminths and other risk factors for stillbirth in Ghana. Infect Dis Obstet Gynecol (2010) 0.94
Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations? Am J Clin Nutr (2011) 0.88
Multiple micronutrient supplementation improves vitamin B₁₂ and folate concentrations of HIV infected children in Uganda: a randomized controlled trial. Nutr J (2011) 0.86
Micronutrients, N-acetyl cysteine, probiotics and prebiotics, a review of effectiveness in reducing HIV progression. Nutrients (2010) 0.85
Sub-optimal vitamin B-12 levels among ART-naïve HIV-positive individuals in an urban cohort in Uganda. PLoS One (2012) 0.84
Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions. Alcohol Clin Exp Res (2016) 0.83
Vitamin A and vitamin B-12 concentrations in relation to mortality and morbidity among children born to HIV-infected women. J Trop Pediatr (2009) 0.82
Nutrition and HIV-Positive Pregnancy. J Perinat Educ (2003) 0.80
Habitual nutrient intake in HIV-infected youth and associations with HIV-related factors. AIDS Res Hum Retroviruses (2014) 0.78
Effect of Vitamin B12 and folic acid supplementation on neuropsychiatric symptoms and immune response in HIV-positive patients. J Neurosci Rural Pract (2016) 0.77
Association between Food Insecurity and Procurement Methods among People Living with HIV in a High Resource Setting. PLoS One (2016) 0.75
Micronutrient supplementation in adults with HIV infection. Cochrane Database Syst Rev (2017) 0.75
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med (1996) 10.49
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer (2006) 6.59
Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol (1997) 5.94
Changes in T and non-T lymphocyte subsets following seroconversion to HIV-1: stable CD3+ and declining CD3- populations suggest regulatory responses linked to loss of CD4 lymphocytes. The Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 4.92
"Sick of Smoking": evaluation of a targeted minimal smoking cessation intervention in general practice. Med J Aust (1990) 4.11
Prospective studies of the effect of breast feeding on incidence of infection and allergy. Acta Paediatr Scand (1979) 3.55
Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology (1993) 3.53
Immunocompetence in undernutrition. J Pediatr (1972) 3.11
A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years. J Allergy Clin Immunol (1989) 3.08
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int (2006) 3.03
Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol (1997) 2.92
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation. Ann Intern Med (1990) 2.75
Nutrition, immunity, and infection: present knowledge and future directions. Lancet (1983) 2.66
Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol (1997) 2.48
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
Potential factors affecting adherence with HIV therapy. AIDS (1997) 2.44
Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet (1994) 2.38
Association of influenza immunization with reduction in mortality in an elderly population. A prospective study. Arch Intern Med (1988) 2.30
Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis (1995) 2.25
Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med (1986) 1.89
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study. Lancet (1991) 1.89
Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol (1991) 1.76
Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting. N Engl J Med (1986) 1.67
Rosette-forming T lymphocytes and cell-mediated immunity in malnutrition. Br Med J (1974) 1.66
Signs and symptoms of "asymptomatic" HIV-1 infection in homosexual men. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1993) 1.66
Estimating the distribution of times from HIV seroconversion to AIDS using multiple imputation. Multicentre AIDS Cohort Study. Stat Med (1990) 1.65
Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr (1992) 1.65
Racial and ethnic differences in human immunodeficiency virus type 1 (HIV-1) seroprevalence among homosexual and bisexual men. The Multicenter AIDS Cohort Study. Am J Epidemiol (1993) 1.61
Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.61
Bacterial pneumonia in adult populations with human immunodeficiency virus (HIV) infection. Am J Epidemiol (1993) 1.59
Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study. N Engl J Med (1993) 1.58
A retrospective study of childhood mortality and spontaneous abortion in HIV-1 infected women in urban Malawi. Int J Epidemiol (1992) 1.56
Opsonic activity, phagocytosis, and bactericidal capacity of polymorphs in undernutrition. Arch Dis Child (1972) 1.55
Comparison of a tuberculin interferon-gamma assay with the tuberculin skin test in high-risk adults: effect of human immunodeficiency virus infection. J Infect Dis (1997) 1.54
Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children. Br Med J (1975) 1.52
Penicillin allergy: anti-penicillin IgE antibodies and immediate hypersensitivity skin reactions employing major and minor determinants of penicillin. Arch Dis Child (1980) 1.49
South Australian hypertension survey. General practitioner knowledge and reported management practices--a cause for concern? Med J Aust (1992) 1.49
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1994) 1.47
Traditional vaginal agents: use and association with HIV infection in Malawian women. AIDS (1995) 1.46
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. J Clin Invest (1997) 1.46
Acute respiratory illness in Adelaide children--the influence of child care. Med J Aust (1991) 1.45
Fetal malnutrition and postnatal immunocompetence. Am J Dis Child (1975) 1.44
Serum thymic hormone activity and cell-mediated immunity in healthy neonates, preterm infants, and small-for-gestational age infants. Pediatrics (1981) 1.40
Excessive intake of zinc impairs immune responses. JAMA (1984) 1.40
Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection. AIDS Res Hum Retroviruses (1990) 1.39
Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med (1993) 1.39
Stress and acute respiratory infection. Am J Epidemiol (1986) 1.36
High socioeconomic status is a risk factor for human immunodeficiency virus type 1 (HIV-1) infection but not for sexually transmitted diseases in women in Malawi: implications for HIV-1 control. J Infect Dis (1993) 1.35
HIV-1 infection: no evidence of cognitive decline during the asymptomatic stages. The Multicenter AIDS Cohort Study. Neurology (1990) 1.34
Interactions of nutrition, infection and immune response. Immunocompetence in nutritional deficiency, methodological considerations and intervention strategies. Acta Paediatr Scand (1979) 1.32
Impaired immunocompetence associated with iron deficiency. J Pediatr (1975) 1.32
Reduced bactericidal capacity of polymorphs in iron deficiency. Arch Dis Child (1973) 1.32
Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope. Identification by DNA fingerprinting. JAMA (1997) 1.30
Cell-mediated immunity in genetically obese C57BL/6J ob/ob) mice. Am J Clin Nutr (1980) 1.29
Zidovudine and stavudine sequencing in HIV treatment planning: findings from the CHORUS HIV cohort. J Acquir Immune Defic Syndr (2001) 1.29
Immunological picture in Indian childhood cirrhosis. Lancet (1970) 1.29
Impact of tuberculosis control measures and crowding on the incidence of tuberculous infection in Maryland prisons. Clin Infect Dis (1997) 1.29
A prospective randomized controlled trial of cefoxitin versus clindamycin-aminoglycoside in mixed anaerobic-aerobic infections. Surg Gynecol Obstet (1982) 1.28
Lymphocyte subpopulations in human malnutrition: cytotoxic and suppressor cells. Pediatrics (1977) 1.25
Antibody formation in first and second generation offspring of nutritionally deprived rats. Science (1975) 1.23
Dietary micronutrient intake and risk of progression to acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus type 1 (HIV-1)-infected homosexual men. Am J Epidemiol (1993) 1.23
Effects of micronutrient intake on survival in human immunodeficiency virus type 1 infection. Am J Epidemiol (1996) 1.21
Letter: Immunocompetence in low-birth-weight infants after intrauterine malnutrition. Lancet (1974) 1.20
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study. J Infect Dis (1996) 1.20
Interaction of socioeconomic status and provider practices as predictors of immunization coverage in Virginia children. Pediatrics (1995) 1.19
Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS (1997) 1.19
Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS Cohort Study Investigators. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.19
Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis. Allergy (2012) 1.18
A survey of occupational blood contact and HIV infection among traditional birth attendants in Rwanda. AIDS (1994) 1.18
Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med (1994) 1.17
Anaphylactoid reaction to methylprednisolone pulsed therapy for multiple sclerosis. Neurology (1984) 1.15
Acute respiratory illness in Adelaide children: breast feeding modifies the effect of passive smoking. J Epidemiol Community Health (1990) 1.14
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.13
Numerical and functional deficiency in T helper cells in protein energy malnutrition. Clin Exp Immunol (1983) 1.13
Cell-mediated immunity in nutritional imbalance. Fed Proc (1980) 1.13
Nutritional support improves antibody response to influenza virus vaccine in the elderly. Br Med J (Clin Res Ed) (1985) 1.12
Serum complement and immunoconglutinin in malnutrition. Arch Dis Child (1975) 1.12
Serum immunoglobulin levels in children with acute lymphoblastic leukaemia and their mothers and sibs. Arch Dis Child (1972) 1.12
High rate of transmission of tuberculosis in an office: impact of delayed diagnosis. Clin Infect Dis (1995) 1.12
Immunological aspects of human milk. Nutr Rev (1978) 1.11
Racial differences in rate of CD4 decline in HIV-1-infected homosexual men. AIDS (1996) 1.11
Predictive value of cord blood IgE in the development of atopic disease and role of breast-feeding in its prevention. Clin Allergy (1985) 1.11
Sugar intolerance in malnourished infants and children. Br Med J (1968) 1.10
Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids (1999) 1.10
Histologic development of cervical ectopy: relationship to reproductive hormones. Sex Transm Dis (2000) 1.09
Nutrition as a critical determinant in susceptibility to infection. World Rev Nutr Diet (1976) 1.09
Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr (1988) 1.08
Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Indian childhood cirrhosis--a re-evaluation of its pathomorphologic features and their significance in the light of clinical data and natural history of the disease. Indian J Med Res (1972) 1.07
Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA (1987) 1.06